Claristep filtration system: fast, easy and reliable sample preparation
Easy, reliable and convenient to use: the new Claristep filtration system enables fast clarification of small sample volumes for subsequent analysis.
Fast small-volume clarification that does not add leachables or extractables to the original sample.
Preparing samples by clarification is an essential step prior to nearly all analytical techniques, such as high pressure liquid chromatography (HPLC). This filtration step to eliminate particles is crucial for maintaining the integrity of chromatography columns and for maximizing their operating life time. In addition, as the sensitivity of automated analytical instruments continues to improve, they increasingly require less volume to operate to maximize throughput.
Fast small-volume clarification that does not add leachables or extractables to the original sample is indispensable for achieving the best analytical results. To meet these requirements, Sartorius has developed a new, easy-to-use and straightforward filtration setup. The manually operated Claristep filtration system consisting of a station and filter units offers a novel way for clarifying samples prior to analysis.
The Claristep station consists of a base, a lid and an exchangeable tray for easy and accurate positioning of sample vials and Claristep filter units. The patent-pending design features unique grooves in the station’s lid and matching guide ridges on Claristep filter units to enable intuitively correct alignment and convenient handling of the system. The grooves automatically guide the filter unit caps into the correct positions for simultaneous and accurate cap closure.
Claristep enables up to eight samples to be simultaneously filtered, without needing any power supply or a vacuum/pressure source. Single-use Claristep filter units with RC membranes are designed for sample volumes of 60 μL to 600 μL. Their hold-up volume is less than 30 μL. The units have been optimized for solvents and aqueous solutions and provide maximum chemical compatibility as well as exceptionally low non-specific binding of analytes.
The contact time of the samples with the filters and the caps is extremely short, ensuring optimal, contamination-free results. Filtrates are collected in any 12 × 32 mm outer diameter vials of the user’s choice based on the analytical method to be performed.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.